These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 25357107)

  • 1. Methylated TIMP-3 DNA in body fluids is an independent prognostic factor for gastric cancer.
    Yu JL; Lv P; Han J; Zhu X; Hong LL; Zhu WY; Wang XB; Wu YC; Li P; Ling ZQ
    Arch Pathol Lab Med; 2014 Nov; 138(11):1466-73. PubMed ID: 25357107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced serum methylated p16 DNAs is associated with the progression of gastric cancer.
    Wu YC; Lv P; Han J; Yu JL; Zhu X; Hong LL; Zhu WY; Yu QM; Wang XB; Li P; Ling ZQ
    Int J Clin Exp Pathol; 2014; 7(4):1553-62. PubMed ID: 24817951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic role of APC and RASSF1A promoter methylation status in cell free circulating DNA of operable gastric cancer patients.
    Balgkouranidou I; Matthaios D; Karayiannakis A; Bolanaki H; Michailidis P; Xenidis N; Amarantidis K; Chelis L; Trypsianis G; Chatzaki E; Lianidou ES; Kakolyris S
    Mutat Res; 2015 Aug; 778():46-51. PubMed ID: 26073472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of the methylated cytosine-phosphate-guanine sites of protocadherin-10 promoter for evaluating the prognosis of gastric cancer.
    Deng J; Liang H; Ying G; Dong Q; Zhang L; Yu J; Fan D; Hao X
    J Am Coll Surg; 2014 Nov; 219(5):904-13. PubMed ID: 25260683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating methylated THBS1 DNAs as a novel marker for predicting peritoneal dissemination in gastric cancer.
    Hu XY; Ling ZN; Hong LL; Yu QM; Li P; Ling ZQ
    J Clin Lab Anal; 2021 Sep; 35(9):e23936. PubMed ID: 34390026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinase 2 (MMP-2) and their tissue inhibitor 2 (TIMP-2) in gastric cancer patients.
    Łukaszewicz-Zając M; Mroczko B; Guzińska-Ustymowicz K; Pryczynicz A; Gryko M; Kemona A; Kędra B; Szmitkowski M
    Adv Med Sci; 2013; 58(2):235-43. PubMed ID: 24384769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation of ASC/TMS1 promoter is associated with poor prognosis of patients with gastric cancer.
    Wu L; Zhang C; Wang X; Ding X; Deng J; Liang H
    Clin Transl Oncol; 2016 Mar; 18(3):296-303. PubMed ID: 26260914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of aberrant methylation as a tumor marker in serum of patients with gastric cancer.
    Ichikawa D; Koike H; Ikoma H; Ikoma D; Tani N; Otsuji E; Kitamura K; Yamagishi H
    Anticancer Res; 2004; 24(4):2477-81. PubMed ID: 15330201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive correlation of tissue inhibitor of metalloproteinase-3 and death-associated protein kinase hypermethylation in head and neck squamous cell carcinoma.
    Nayak CS; Carvalho AL; Jeronimo C; Henrique R; Kim MM; Hoque MO; Chang S; Jiang WW; Koch W; Westra W; Sidransky D; Califano J
    Laryngoscope; 2007 Aug; 117(8):1376-80. PubMed ID: 17592394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic inactivation of BCL6B, a novel functional tumour suppressor for gastric cancer, is associated with poor survival.
    Xu L; Li X; Chu ES; Zhao G; Go MY; Tao Q; Jin H; Zeng Z; Sung JJ; Yu J
    Gut; 2012 Jul; 61(7):977-85. PubMed ID: 21917650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating Methylated XAF1 DNA Indicates Poor Prognosis for Gastric Cancer.
    Ling ZQ; Lv P; Lu XX; Yu JL; Han J; Ying LS; Zhu X; Zhu WY; Fang XH; Wang S; Wu YC
    PLoS One; 2013; 8(6):e67195. PubMed ID: 23826230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum TIMP-1 in gastric cancer patients: a potential prognostic biomarker.
    Wang CS; Wu TL; Tsao KC; Sun CF
    Ann Clin Lab Sci; 2006; 36(1):23-30. PubMed ID: 16501233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AKR1B10, a good prognostic indicator in gastric cancer.
    Yao HB; Xu Y; Chen LG; Guan TP; Ma YY; He XJ; Xia YJ; Tao HQ; Shao QS
    Eur J Surg Oncol; 2014 Mar; 40(3):318-24. PubMed ID: 24406159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of expression and epigenetic profiling of TUSC1 in gastric cancer.
    Kanda M; Shimizu D; Nomoto S; Hibino S; Oya H; Takami H; Kobayashi D; Yamada S; Inokawa Y; Tanaka C; Fujii T; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    J Surg Oncol; 2014 Aug; 110(2):136-44. PubMed ID: 24700496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accumulation of DNA methylation is associated with tumor stage in gastric cancer.
    Oue N; Mitani Y; Motoshita J; Matsumura S; Yoshida K; Kuniyasu H; Nakayama H; Yasui W
    Cancer; 2006 Mar; 106(6):1250-9. PubMed ID: 16475210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue inhibitor of metalloproteinase-3 (TIMP-3) gene is methylated in the development of esophageal adenocarcinoma: loss of expression correlates with poor prognosis.
    Darnton SJ; Hardie LJ; Muc RS; Wild CP; Casson AG
    Int J Cancer; 2005 Jun; 115(3):351-8. PubMed ID: 15688381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Tissue Inhibitor of Metalloproteinase-3 Gene Methylation and Gastric Cancer Risk: A Meta-Analysis.
    Cao J; Li Z; Yang L; Liu C; Luan X
    Genet Test Mol Biomarkers; 2016 Aug; 20(8):427-31. PubMed ID: 27314831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant SOX11 promoter methylation is associated with poor prognosis in gastric cancer.
    Xu X; Chang X; Li Z; Wang J; Deng P; Zhu X; Liu J; Zhang C; Chen S; Dai D
    Cell Oncol (Dordr); 2015 Jun; 38(3):183-94. PubMed ID: 25801783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of pleiotrophin is a prognostic marker for patients with gastric cancer.
    Hu H; Li C; Cai S; Zhu C; Tian Y; Zheng J; Hu J; Chen C; Liu W
    Hepatogastroenterology; 2014; 61(133):1478-82. PubMed ID: 25436328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the clinical feasibility: The direct bisulfite genomic sequencing for examination of methylated status of protocadherin10 (PCDH10) promoter to predict the prognosis of gastric cancer.
    Hou YC; Deng JY; Zhang RP; Xie XM; Cui JL; Wu WP; Hao XS; Liang H
    Cancer Biomark; 2015; 15(5):567-73. PubMed ID: 26406945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.